August 31, 2016 / 9:57 PM / in a year

Sunovion Pharma to buy Canada's Cynapsus for $624 mln

Aug 31 (Reuters) - Sunovion Pharmaceuticals Inc, a unit of Japan's Dainippon Sumitomo Pharma Co Ltd, said it would buy Canada's Cynapsus Therapeutics Inc for about $624 million.

Sunovion said it would buy Cynapsus for $40.50 per share in cash.

Cynapsus's Toronto-listed stock closed at C$24.48 ($18.68) on Wednesday.

The deal, which is expected to close in the fourth quarter, "reflects Sunovion's global strategy to expand and diversify its portfolio in key therapeutic areas, including neurology," Sunovion said. ($1 = C$1.31) (Reporting by Vishaka George in Bengaluru; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below